Enochian Biosciences Inc (ENOB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7000 unch (unch) 08/04/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7000 unch (unch) -
for Fri, Aug 4th, 2023
Results
download Want to compare other data? Select Fields| Symbol | ENOB | WHWK | SKYE | ||
| Company | Enochian Biosciences Inc | Whitehawk Therapeutics Inc | Skye Bioscience Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.7300 | 1.5100 | 1.8200 | ||
| High | 0.7500 | 1.5100 | 1.9200 | ||
| Low | 0.7000 | 1.3900 | 1.7500 | ||
| Last | 0.7000 | 1.4500 | 1.8200 | ||
| Change | unch | -0.0600 | +0.0300 | ||
| % Change | unch | -3.97% | +1.68% | ||
| Volume | 88,300 | 54,900 | 415,800 | ||
| 20-Day Average Volume | 436,705 | 92,145 | 1,707,835 | ||
| Previous Close | 0.7000 | 1.5100 | 1.7900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5940 | 1.6310 | 1.5067 | ||
| 20-Day Raw Stochastic | 79.27% | 11.21% | 26.29% | ||
| 20-Day Relative Strength | 54.14% | 30.05% | 47.95% | ||
| Weighted Alpha | -71.44 | -43.32 | -72.66 | ||
| Today's Opinion | 64% Sell | 88% Sell | 88% Sell | ||
| Previous Opinion | 64% Sell | 88% Sell | 88% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.68% since 07/28/23 | -7.64% since 04/17/25 | +26.83% since 04/17/25 | ||
| Low | 0.5700 on 07/31/23 | 1.3900 on 04/25/25 | 1.3600 on 04/21/25 | ||
| High | 0.7638 on 08/01/23 | 1.6200 on 04/21/25 | 1.9200 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | +39.05% since 07/03/23 | -25.64% since 03/25/25 | -22.88% since 03/25/25 | ||
| Low | 0.4210 on 07/06/23 | 1.3900 on 04/25/25 | 1.1400 on 04/08/25 | ||
| High | 0.7638 on 08/01/23 | 1.9622 on 03/26/25 | 3.7270 on 04/15/25 | ||
| 3-Month | |||||
| %Chg | -42.15% since 05/04/23 | -53.82% since 01/24/25 | -34.53% since 01/24/25 | ||
| Low | 0.3928 on 06/29/23 | 1.3900 on 04/25/25 | 1.1400 on 04/08/25 | ||
| High | 1.2800 on 05/05/23 | 3.1300 on 01/27/25 | 4.2500 on 01/31/25 | ||
| 6-Month | |||||
| %Chg | -36.36% since 02/03/23 | -27.86% since 10/25/24 | -63.82% since 10/25/24 | ||
| Low | 0.3928 on 06/29/23 | 1.3900 on 04/25/25 | 1.1400 on 04/08/25 | ||
| High | 1.3300 on 04/19/23 | 3.8120 on 01/08/25 | 5.9600 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,799 | 40,997 | 40,268 | ||
| Shares Outstanding, K | 58,284 | 24,697 | 30,975 | ||
| Annual Sales | 0 | 25,980,000 | 0 | ||
| Annual Net Income | -113,430,000 | -63,690,000 | -26,570,000 | ||
| Last Quarter Sales | 0 | 7,240,000 | 0 | ||
| Last Quarter Net Income | -4,330,000 | -18,270,000 | -9,750,000 | ||
| 60-Month Beta | 1.09 | 0.75 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.08 on 05/12/23 | -0.67 on 03/18/25 | -0.24 on 03/20/25 | ||
| Latest Earnings Date | 08/11/23 | 05/14/25 | 05/09/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||